![](/img/cover-not-exists.png)
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)
A.Michael Lincoff, Neal S. Kleiman, Kandace Kottke-Marchant, Elizabeth S. Maierson, Kelly Maresh, Katherine E. Wolski, Eric J. TopolVolume:
143
Year:
2002
Language:
english
DOI:
10.1067/mhj.2002.122173
File:
PDF, 117 KB
english, 2002